机构：[1]Shandong Cancer Hospital and Institute, Jinan/CN,[2]Anyang Cancer Hospital, Anyang/CN,[3]Weihai Municipal Hospital, Weihai/CN,[4]Cancer Hospital of Henan Province, Zhengzhou/CN,河南省肿瘤医院[5]Anhui Provincial Cancer Hospital, Hefei/CN,[6]The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou/CN,广东省中医院[7]The Affiliated Tumor Hospital of Xinjiang Medical University, Wulumuqi/CN,[8]The Second Affiliated Hospital of Anhui Medical University, Hefei/CN,[9]Qianfoshan Hospital of Shandong Province, Jinan/CN,[10]The Second People‘S Hospital of Wuhu, Wuhu/CN,[11]The First Affiliated Hospital of Henan University of Science and Technology, Luoyang/CN,[12]The Central Hospital of Qingdao, Qingdao/CN,[13]Yantai Yu Huang Ding Hospital, Yantai/CN,[14]Tangdu Hospital of Air Force Military Medical University, Xi’An/CN,[15]Beijing Cancer Hospital, Beijing/CN,[16]The Cancer Hospital of Harbin Medical University, Harbin/CN,[17]Jiangxi Cancer Hospital, Nanchang/CN,[18]Shanxi Province Tumor Hospital, Xi’An/CN,[19]The Second Affiliated Hospital of Xi’An Jiaotong University, Xi’An/CN,[20]Chongqing Cancer Hospital, Chongqing/CN,[21]Sichuan Cancer Hospital, Chengdu/CN,四川省肿瘤医院[22]Peking University Shougang Hospital, Beijing/CN,[23]Navy General Hospital, Beijing/CN,[24]Affiliated Hospital of Weifang Medical University, Weifang/CN,[25]Qilu Hospital of Shandong University, Jinan/CN,[26]Cancer Hospital Chinese Academy of Medical Sciences, Beijing/CN
第一作者机构：[1]Shandong Cancer Hospital and Institute, Jinan/CN,
推荐引用方式(GB/T 7714)：
L. Xing,J. Wang,L. Li,et al.A Randomized, Double-Blind, Placebo-Controlled Trial of Chemotherapy Combined with Yangzheng Xiaoji in Advanced NSCLC[J].JOURNAL OF THORACIC ONCOLOGY.2018,13(10):S359-S360.doi:10.1016/j.jtho.2018.08.326.
APA：
L. Xing,J. Wang,L. Li,Z. Ma,C. Hu...&J. Yu.(2018).A Randomized, Double-Blind, Placebo-Controlled Trial of Chemotherapy Combined with Yangzheng Xiaoji in Advanced NSCLC.JOURNAL OF THORACIC ONCOLOGY,13,(10)
MLA：
L. Xing,et al."A Randomized, Double-Blind, Placebo-Controlled Trial of Chemotherapy Combined with Yangzheng Xiaoji in Advanced NSCLC".JOURNAL OF THORACIC ONCOLOGY 13..10(2018):S359-S360
医学